Does glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes? - Wikidata - awgldk - TriplyDB

Does glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes?

Does glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes?

http://www.wikidata.org/entity/Q34570576

about

Echocardiography and Electrocardiography Variables Correlate With the New York Heart Association classification: An Observational Study of Ischemic Cardiomyopathy Patients.Dispersion of ventricular repolarization in relation to cardiovascular risk factors in hypertension Xanthine oxidase inhibition alleviates the cardiac complications of insulin resistance: effect on low grade inflammation and the angiotensin system.Reduction in Kv Current Enhances the Temporal Dispersion of the Action Potential in Diabetic Myocytes: Insights From a Novel Repolarization Algorithm.Hyperglycemia induces defective Ca2+ homeostasis in cardiomyocytes.Zingerone alleviates the delayed ventricular repolarization and AV conduction in diabetes: Effect on cardiac fibrosis and inflammation.Effect of sodium-glucose co-transporter-2 inhibitors on impaired ventricular repolarization in people with Type 2 diabetes.

P2860

Q33879588-F8E96D1B-F2A5-46E2-8ED9-1D38EFA60796 Q35045898-0AD0D471-2B6E-4FB6-BEAF-1C05E7BD500A Q35166562-0825C448-EB82-401E-914D-82F652BED14E Q36714022-3F4BD048-80CF-416B-9EBD-C15878A4DFF5 Q39158044-BACC81EB-C7C6-40F1-A95A-EA311CB414BC Q47144195-84543C0C-CE75-459E-A705-86F780823D49 Q48132247-A019991B-0538-4F6D-9B2E-10B2B1B26E1E

P2860

Does glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes?

http://www.wikidata.org/entity/Q34570576

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Does glycemic control reverse ...... larization in type 2 diabetes?

@ast

Does glycemic control reverse ...... larization in type 2 diabetes?

@en

Does glycemic control reverse ...... larization in type 2 diabetes?

@nl

type

label

Does glycemic control reverse ...... larization in type 2 diabetes?

@ast

Does glycemic control reverse ...... larization in type 2 diabetes?

@en

Does glycemic control reverse ...... larization in type 2 diabetes?

@nl

prefLabel

Does glycemic control reverse ...... larization in type 2 diabetes?

@ast

Does glycemic control reverse ...... larization in type 2 diabetes?

@en

Does glycemic control reverse ...... larization in type 2 diabetes?

@nl

P1433

Q34570576-A3944A6A-69F8-40C9-A633-D5B048C2C96E

P1476

Q34570576-67D8CC92-60A0-4F70-8DD4-B4406951ED35

P2093

Q34570576-17D6B2AC-49FA-4FBA-9E48-B50AE5650C61

Q34570576-211F0670-DEF8-4C60-B3F3-3F600486B263

Q34570576-231032D7-2607-435D-8C92-15B8C48D1AD8

Q34570576-5C1208D3-49E8-44A4-8C4E-754362A47F13

Q34570576-9A0A1254-05D0-4E66-A90C-B9DD02501AF5

Q34570576-B05B3324-2ADB-4091-8940-BD5E842FEC66

Q34570576-C0105A22-AB7D-447B-A8EB-4AC882C7332A

Q34570576-D9052357-6FDC-4AE3-A150-B6ABD0198EA0

Q34570576-E90256A0-D8D7-4951-AAD0-BD517731F8D5

Q34570576-F9A65253-79A2-4F3E-9155-64E64EDDC4DA

P2860

Q34570576-0E6F0115-A54F-4157-ABC4-3E5B29AA9FBD

Q34570576-1204B5A5-197C-4753-9DDD-E1B3F164CDE6

Q34570576-17CA9F21-58B9-4EA2-BA96-98CE062F1F82

Q34570576-288C4CEC-7C87-4F7B-99E4-3D93434A293E

Q34570576-46C5026D-951C-4620-B790-B5A94BD89A60

Q34570576-4C166C48-74E4-4E19-882E-6B053AE00DAA

Q34570576-508138FD-98C7-4B33-8E35-C24674266C7D

Q34570576-518A0546-DCC0-4C52-9931-8457275361DC

Q34570576-5BCCBF69-8AF6-47B3-936B-1FC9A3C95461

Q34570576-5CE259E2-173E-4575-8343-C78BF08C4E9A

P2888

Q34570576-CD4728D1-847E-4D41-B06C-B26DFF5AD51E

P304

Q34570576-B5B39C2F-FDC1-4A84-8ABA-31D129070973

P31

Q34570576-92C1E46A-CFDE-416A-88B2-5E23971FD3E7

P356

Q34570576-98B9BC4B-F9AA-45FF-8F77-71B599B2789C

P407

Q34570576-33B295A6-D720-4F33-BB62-300A92156487

P478

Q34570576-4783C04C-5D33-43E8-9989-786E259E4C92

P50

Q34570576-6406E6BE-B573-4A13-9BC5-9791E4A2B425

P577

Q34570576-DB32BCE5-79EE-4136-AF90-BD62F6AE98D6

P5875

Q34570576-C62D4266-3C2F-465C-9785-8EF17F8518C0

P6179

Q34570576-344DA7BC-B481-4260-B983-4EB2C3A0DED3

P698

Q34570576-9FE4B003-46FE-460C-BB29-AD9FF7C0AC00

P921

Q34570576-E293C6A9-64F5-4B09-8355-85999F3A72D6

P932

Q34570576-5A737473-3657-4B6A-B7D5-9299AF0E5989

P356

S12933-014-0125-8

P1433

Cardiovascular Diabetology

P1476

Does glycemic control reverse ...... larization in type 2 diabetes?

@en

P2093

Hiromichi Murase

http://www.w3.org/2001/XMLSchema#string

Hiroshi Akasaka

http://www.w3.org/2001/XMLSchema#string

Makoto Ogasawara

http://www.w3.org/2001/XMLSchema#string

Masaya Tanno

http://www.w3.org/2001/XMLSchema#string

Shigeyuki Saitoh

http://www.w3.org/2001/XMLSchema#string

Takayuki Miki

http://www.w3.org/2001/XMLSchema#string

Tatsuya Sato

http://www.w3.org/2001/XMLSchema#string

Tetsuji Miura

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Tobisawa

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Yano

http://www.w3.org/2001/XMLSchema#string

P2860

Increased QT interval dispersion predicts 15-year cardiovascular mortality in type 2 diabetic subjects: the population-based Casale Monferrato Study

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

10-year follow-up of intensive glucose control in type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

Diabetic cardiomyopathy: pathophysiology and clinical features

Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome.

P2888

s12933-014-0125-8

P304

125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12933-014-0125-8

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264987981

http://www.w3.org/2001/XMLSchema#string

P6179

1002749878

http://www.w3.org/2001/XMLSchema#string

P698

25142437

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4243814

http://www.w3.org/2001/XMLSchema#string